Clearly visible results.

Acanya is clinically proven to treat both inflammatory and non-inflammatory lesions

Results from two double-blind, randomized, controlled studies of Acanya Gel in patients with moderate to severe acne

35% of subjects in clinical trials had at least a 2-grade improvement in Evaluator’s Global Severity Score (EGSS)** with Acanya at week 12 (vehicle 17%)

**EGSS grades are defined as: 0=clear; 1=almost clear; 2=mild; 3=moderate; 4=severe; 5=very severe.

NEXT: Patient-reported improvement

Safety Considerations

Discontinuation is recommended if significant diarrhea, bloody diarrhea, severe abdominal cramping, or colitis (including pseudomembranous colitis) develops. Clindamycin taken orally or through IV may result in severe colitis, which may result in death.

Clearly visible results.

67% of patients reported improvement

As reported in pooled results from 2 double-blind, randomized, controlled studies of 2813 patients with moderate to severe acne (secondary endpoint).2

Patient self-assessment results

Following 12 weeks of treatment, 67% of patients treated with Acanya Gel in pivotal studies rated their acne as “clear,” “almost clear,” or having “marked improvement.”

Data reflect intent-to-treat population.

NEXT: Before & after images

Safety Considerations

The most common local adverse events in clinical trials were mild and moderate erythema, scaling, itching, burning and stinging.